AzTrials
AzTrials

Autism Spectrum DisorderNCT04166591

Study 1 Replication and Extension of Prior Work

A study testing Overheard Speech and Addressed Speech in people with Autism Spectrum Disorder, run by New York University at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this research is to explore abilities to learn word meanings from overheard conversations in children with ASD (and, as a control, typically developing children). Specific Aim 1 (Experiment 1): Subaim 1a: Identify child characteristics associated with learning from overhearing. Read more about this study

Who is it for?
Ages 18 to 71 monthsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Overheard Speech and Addressed Speech
Could I receive a placebo?
No, everyone receives an active treatment
How many people
342 participants
Where
2 sitesUnited States
Study dates
5 Jan 2021to 5 Dec 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 71 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • children with or without a diagnosis of ASD between 18 to 71 months of age

Who cannot join

  • native language is not English
  • born premature (< 36 weeks)
  • has uncorrected hearing or vision impairments
  • has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
  • has a history of photosensitive epileptic seizures

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Emerson College

    Boston, Massachusetts, 02116

  • New York University

    New York, New York, 10012

Other trials in United States

About this study

Official title: Learning New Words From Overhearing in Children With ASD

The goal of this research is to explore abilities to learn word meanings from overheard conversations in children with ASD (and, as a control, typically developing children).

Specific Aim 1 (Experiment 1): Subaim 1a: Identify child characteristics associated with learning from overhearing. In a prior study, the investigators found that 13 children with ASD were able to learn the meanings of novel words that they heard used in a conversation involving two adults. In the current study, the investigators aim to study a larger sample to identify what child characteristics are associated with good learning in an overhearing situation as compared to a situation in which the child is directly taught the new word. Subaim 1b: Assess retention and generalization of words learned from overhearing. The investigators will re-test children on their knowledge of the word meanings after a 10-minute delay to see if they both retain the word meanings and can generalize the new words to new situations.

Being tested
Overheard Speech, Addressed Speech
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Overheard SpeechBehavioural

    New words are introduced with the child as an observer rather directly taught.

  • Addressed SpeechBehavioural

    New words are introduced directly to the child by an experimenter.

Study groups in NCT04166591
Study groupRoleWhat they receive
AddressedExperimentalChildren participate in an interaction with an experimenter who uses the word to be learned.
Receives: Behavioral: Addressed Speech
OverheardExperimentalChildren observe while an experimenter uses the word to be learned in an interaction with another experimenter.
Receives: Behavioral: Overheard Speech

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Children Who Select the Target Object as Measured by Gaze Preference.

    Children are prompted to identify the object that is associated with the target word.

    Measured: immediately after viewing 3-minute interaction

  2. Number of Children Who Select the Target Object as Measured by Gaze Preference.

    Children are prompted to identify the object that is associated with the target word.

    Measured: 5 minutes after viewing interaction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2019
  2. Study start5 Jan 2021
  3. Primary completion1 Dec 2024
  4. Study completion5 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
342 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04166591
Sponsor's protocol ID
280521
Status last verified
Nov 2024
First submitted
31 Oct 2019
Last updated
4 Apr 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Overheard Speech and Addressed Speech in people with Autism Spectrum Disorder, run by New York University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Mar 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Children Who Select the Target Object as Measured by Gaze Preference. (time frame: immediately after viewing 3-minute interaction). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in